Replies to post #107783 on Biotech Values

[DewDiligence]

That sounds like BS, genisi. What exactly does it mean to “outsource about 40%” of generic Lovenox?

We know that the bulk heparin for most LMWH drugs comes from pigs in China, but that’s not the issue. For the production of generic Lovenox per se, the job is either outsourced or it isn’t, and Teva has already acknowledged that it is.

[y3maxx]

genisi..with respect...

""Just got an indirect (from an analyst who met Teva's CFO) reply. Before asking me more questions please bear in mind these facts:
I wasn't present, I'm translating from Hebrew""

...So your source is an indirect, Hebrew first language, analyst?

Sorry, I read "Planted Info"

and how convenient this Indirect Info came out yesterday a.m.

...Looking forward to your next "timely indirect info"

jmo, I have no doubt in my mind that w/ an Israeli Head Office, Teva skirts/delays PR'ing negative FDA rulings to it's longest legal advantage.

y3

[osofun]

Genisi

Did you ever hear from the 2nd analyst ?


I have emailed two analysts and this is the reply from the 1st one. I'll try to post the other if I get it before I leave.

Message #107783

TIA

[exwannabe]

MNTA: Genesi, could you clarify something for me?

In the analyst email that has provoked some debate, some details are very unclear.

Mainly, who is saying what? Is the analyst saying the CFO said this, or is this just the analyst who said this on his own. Who is the "He" in line 1? You referring to the analyst or the analyst referring to the CFO?

Also, the exact phrasing of the 2nd line might help.

I understand it is a translation, could it be somewhat poor?

[No insult to your linguistic skills implied, I honestly have no idea if most all Israelis are fluent in Hebrew].

TIA

[alertmeipp]

"Teva's generic is different from Lupin's. "

That's very different than "Teva's generic is NOT Lupin's. "

[10nisman]

MNTA/TEVA

Just got an indirect (from an analyst who met Teva's CFO) reply....He knows about the "rumors". Teva normally do not discuss its API suppliers or product sources. About 40% of this generic product comes from out source. He knows ItalFarmaco and its drug marketed in India by Lupin. Teva's generic is different from Lupin's.

For a company the size of Teva, with the amount of drugs on-the market and in the pipeline, why would Teva's CFO have detailed knowledge of tL specifics other than partnership terms and specific financial performance related to the program? Teva's CFO would likely be one of the last executives I would ask to obtain specifics of tL.

Does anyone know how the FDA and Pharma prevent information leaks from their staff? I've spent a long time in the world of public accounting and although the firms have stricter independence rules regarding investment holdings than the SEC mandates, it is very common for staff working on M&A deals and other confidential projects to speak openly about the specifics. Their rationale is generally if we know about it so do a lot of other people (I-bankers, lawyers, certain employees, etc.).

So, I find it surprising in today's world of instant communication (text messages, tweets, facebook, etc.) that someone with intimate knowledge of tL hasn't accidentially or purposefully leaked information to someone they know - other than DD's unnamed person.

10nis